--

Canmab 150mg Trastuzumab Injection




Medicine Detail


Brand Name: Canmab 150mg

Active Ingredient: Trastuzumab

Manufactured by: Biocon Ltd.

Strength: 150mg

Form: Injection

Packing: Pack of 1 Vial

ABOUT CANMAB 150MG INJECTION

Canmab Trastuzumab is one of a group of growth drugs called monoclonal antibodies. Monoclonal antibodies are in some cases called focused on treatments since they work by "focusing on" particular proteins (receptors) on the surface of cells. A few tumors have excessively of a protein called human epidermal development factor receptor 2 (HER2) on the surface of their phones. These are called HER2-positive malignancies. The additional HER2 receptors invigorate the malignancy cells to isolate and develop. Trastuzumab bolts on to the HER2 protein and obstructs the receptor. This prevents the cells from separating and developing. 

USES OF TRASTUZUMAB 150MG INJECTION

Canmab is a tumor medicine that meddles with the development and spread of growth cells in the body. It is, for the most part, used to treat certain sorts of bosom tumor or stomach malignancy. 

SIDE-EFFECTS OF CANMAB TRASTUZUMAB 150MG INJECTION

Some symptoms may happen amid the infusion. Talk your specialist immediately in the event that you feel mixed up, disgusted, woozy, powerless, shy of breath, or on the off chance that you have a migraine, fever, chills, sudden chest torment, wheezing, dry hack, hives, or swelling of your face, lips, tongue, or throat. 

Get crisis medicinal help in the event that you have indications of an unfavorably susceptible response: hives; troublesome breathing; swelling of your face, lips, tongue, or throat. 

This is not a total rundown of every single reaction that may happen. In the event that you have inquiries concerning reactions, contact your social insurance supplier. Call your specialist for therapeutic guidance about symptoms.


Write a review

Note: HTML is not translated!
    Bad           Good
Captcha

Tags: Trastuzumab injection, Canmab Injection, trastuzumab canmab injection